ArticleBMC nephrology2025
Kidney transplant in low resources countries; 6 years of successes and challenges at Benjamin Mkapa Hospital, Tanzania.
Article in BMC nephrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
23 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundKidney transplantation (KT) is the optimal treatment for end-stage renal disease (ESRD), requiring multidisciplinary expertise, infrastructure, and reliable access to immunosuppression. This review examines the establishment and sustainability of a KT program at Benjamin Mkapa Hospital (BMH) in Tanzania since its inception in 2018 through a collaboration with Tokushukai Medical group (TMG) from Japan, highlighting successes, challenges, and long-term prospects. METHODOLOGY: We retrospectively reviewed the methods employed to establish the KT program and analysed data from 37 KT recipients transplanted between March 2018 and July 2024. Statistical analysis (SPSS version 27) yielded median and proportions, and Kaplan-Meier survival curves for patients' survival and graft survival.
resultsBMH successfully established a KT program with TMG collaboration, training 11 medical personnel. The main challenges encountered were shortage of trained staff, inconsistent supply of medical resources and immunosuppressive drugs, long turnaround times for outsourced histocompatibility tests, funding limitations, and a scarcity of kidney donors. Among 37 analysed recipients (70% male, median age 50 years with IQR: 39-56), hypertension (43%) and diabetes (32.5%) were the leading causes of ESRD. The majority of donors were blood-related (84%), with 16% being spouses. Graft survival rates at 1, 3, and 5 years were 94%, 90%, and 90%, respectively, while patient survival rate at 1,3 and 5 were 97%, 81%, and 81%, respectively. The overall estimated mortality rate was 37.3 (95%CI: 14.0-99.4) per 1000 person per years.
conclusionBMH has successfully sustained a KT program led by a local team following training and mentorship from Japanese experts. The overall estimated mortality rate indicated favourable outcomes for kidney transplant recipients in this low-resource setting comparable to those in developed nations. The hospital's six-year experience demonstrates the feasibility of establishing and maintaining KT services in low-income countries.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.